RecruitingNCT06891300
Ketamine and biological factors in suicidal thoughts with depression
About this title
Understanding and Treating Suicidal Ideation With Ketamine
Read the official source — NCT06891300Medication studyAges 18–65CanadaSuicide prevention
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- OttawaSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 8, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 36
- Sponsor
- The Royal's Institute of Mental Health Research
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06891300
- Official title
Show the full official title
Understanding and Treating Suicidal Ideation With Ketamine: A Diffusion Magnetic Resonance Imaging Study
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Ottawa
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is The Royal's Institute of Mental Health Research, a research institute.
Does this study involve medication?
Yes. The study involves medication, including ketamine hydrochloride.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
